Press Releases

We lead the synthetic biology industry, having developed and successfully commercialized the most Lab-to-Market™ ingredients. Our sustainable ingredients are used in thousands of top global brands, including our own family of consumer brands in Clean Beauty and Health markets.

Amyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for Tuesday, November 28, 2017

EMERYVILLE, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) today announced that it will hold a special teleconference to provide additional details on its recently announced expanded strategic alliance with Royal DSM (AEX:DSM.AS) before market open on Tuesday, November 28.

Conference Call: 
Tuesday, November 28, 2017, 8:30 a.m. ET/5:30 a.m. PT 

Dial-in Number: 
(866) 516-3867 (U.S. & International)
Access Code: 5780109

Audio Webcast: 
A live webcast of the call will be available online on the Amyris website. To listen via live webcast, please visit: http://investors.amyris.com. A replay of the webcast will be available on the Investor Relations section of the company's website approximately two hours after the conclusion of the call.

About Amyris

Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.

Amyris, the Amyris logo and No Compromise are registered trademarks of Amyris, Inc.

Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc. 
+1 (510) 740-7481
investor@amyris.com
pr@amyris.com

Contact Us

For media inquiries, please contact: info@amyris.com
For investor inquiries, please contact: investor@amyris.com